Development of a Hydrophobicity-Controlled Delivery System Containing Levodopa Methyl Ester Hydrochloride Loaded into a Mesoporous Silica

• Egile Nagusiak: Tamás Kiss (Egilea), Gábor Katona (Egilea), László Mérai (Egilea), László Janovák (Egilea), Ágota Deák (Egilea), Gábor Kozma (Egilea), Zoltán Kónya (Egilea), Rita Ambrus (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: The drug release of antiparkinsonian drugs is an important issue during the formulation process because proper release kinetics can help to reduce the off periods of Parkinson's disease. A 2-factor, 3-level (3²) full-factorial design was conducted to evaluate...